|
vg- GAL4
|
twist- GAL4
|
scalloped- GAL4
|
eyeless- GAL4
|
collagen- GAL4
|
---|
UAS-Bax-GFP
| 6.8 | 7.6 | 0 | 0 | 0 |
(BA64III) | (36/527) | (46/602) | (0/141) | (0/96) | (0/130) |
UAS-Bax30–192-GFP
| 8.9 | 0.6 | 1.6 | 0 | 0 |
(DBA8II) | (55/616) | (2/315) | (1/59) | (0/120) | (0/137) |
UAS-Bcl-2
| 90.4 | 104 | 97.5 | Â | Â |
(BC57I) | (377/417) | (259/248) | (39/40) | Â | Â |
- UAS transgenic lines for Bax-GFP (BA64III) or Bax 30–192-GFP (DBA8II) or Bcl-2 (BC57I) were screened for lethality using various tissue specific GAL4 lines as indicated. Percent viability was calculated by assessing the number of Bax-GFP or Bax 30–192-GFP or Bcl-2 expressing flies compared to the appropriate sibling control that eclosed at 25°C. Numbers in parenthesis indicate animals screened for analysis.